期刊文献+

BRCA1 affects global DNA methylation through regulation of DNMT1 被引量:5

BRCA1 affects global DNA methylation through regulation of DNMT1
在线阅读 下载PDF
导出
摘要 Global DNA hypomethylation at CpG islands coupled with local hypermethylation is a hallmark for breast cancer, yet the mechanism underlying this change remains elusive. In this study, we showed that DNMT1, which encodes a methylation maintenance enzyme, is a transcriptional target of BRCA1. BRCA1 binds to the promoter of the DNMT1 gene through a potential OCT1 site and the binding is required for maintaining a transcriptional active configuration of the promoter in both mouse and human cells. We further demonstrated that impaired function of BRCA1 leads to global DNA hypomethylation, loss of genomic imprinting, and an open chromatin configuration in several types of tissues examined in a BRCA1 mutant mouse model at premaligant stages. BRCA1 deficiency is also associated with significantly increased expression levels of several protooncogenes, including c-Fos, Ha-Ras, and c-Myc, with a higher expression in tumors, while premalignant mammary epithelial cells displayed an intermediate state between tumors and controls. In human clinical samples, reduced expression of BRCA1 correlates with decreased levels of DNMT1, and reduced methylation of CpG islands. Thus, BRCA1 prevents global DNA hypomethylation through positively regulating DNMT1 expression, and this provides one of mechanisms for BRCAl-associated breast cancer formation.
出处 《Cell Research》 SCIE CAS CSCD 2010年第11期1201-1215,共15页 细胞研究(英文版)
关键词 BRCA1 histone modification DNA methylation DNMT 1 genomic imprinting tumor formation DNA甲基化 BRCA1 基因转录 表达调控 乳腺上皮细胞 CpG岛 机制转变 小鼠模型
  • 相关文献

参考文献62

  • 1Robertson KD, Jones PA. DNA methylation: past, present and future directions. Carcinogenesis 2000; 21:461-467.
  • 2Agrawal A, Murphy R_F, Agrawal DK. DNA methylation in breast and colorectal cancers. ModPatho12007; 20:711-721.
  • 3Siedlecki P, Zielenkiewicz P. Mammalian DNA methyltransferases. Acta Biochim Pol 2006; 53:245-256.
  • 4Lafon-Hughes L, Di Tomaso MV, Mendez-Acuna L, Martinez-Lopez W. Chromatin-remodelling mechanisms in cancer. Mutat Res 2008; 658:191-214.
  • 5Esteller M. Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv Exp Med Biol 2003; 532:39-49.
  • 6Soares J, Pinto AE, Cunha CV, et aL Global DNA hypomethylation in breast carcinoma: correlation with prognostic factors and tumor progression. Cancer 1999; 85:112-118.
  • 7Jackson K, Yu MC, Arakawa K, et al. DNA hypomethylation is prevalent even in low-grade breast cancers. Cancer Biol Ther 2004; 3:1225-1231.
  • 8Jeltsch A. Molecular enzymology of mammalian DNA methyltransferases. Curr Top Microbiol Immunol 2006; 301:203- 225.
  • 9Bonfini L, Karlovich CA, Dasgupta C, Banerjee U. The son of sevenless gene product: a putative activator of Ras. Science 1992; 255:603-606.
  • 10Gonzalo S, Jaco I, Fraga MF, et al. DNA methyltransferases control telomere length and telomere recombination in mammalian cells. Nat Cell Biol 2006; 8:416-424.

同被引文献41

  • 1Castilla MA, Moreno-Bueno G, Romero-Perez L, et al. Micro- RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma[ J]. J Pathol,2011,223 ( 1 ) : 72 - 80.
  • 2Tsou JA, Hagen JA, Carpenter CL. DNA methylation analysis: a powerful new tool for lung cancer diagnosis [ J ]. Oncogene, 2002,21 (35) :5450 -5461.
  • 3Suzuki H, Gabrielson E, Chen W, et aI. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer [J]. Nat Genet, 2002,31 (2) : 141 -149.
  • 4Shi H, Yan PS, Chen CM, et aI. Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells [J]. Cancer Res, 2002, 62 (II) :3214 - 3220.
  • 5Bartel DP. MicroRNAs: target recognition and regulatory functions[J]. Cell,2009,136(2) :215 -233.
  • 6Martello G,Rosato A, Ferrari F ,et al. A microRNA targeting dieer for metastasis control [J]. Cell, 20 10 , 141 (7) : 1195 - 1207.
  • 7Bast RC Jr, Hennessy B, Mills GB. The biology of ovarian cancer: new opportunities for translation [J]. Nat Rev Cancer, 2009 ,9 (6) :415 -428.
  • 8Balch C, Fang F, Matei DE,et al. Minireview , epigenetic changes in ovarian cancer[J]. Endocrinology, 2009 ,ISO (9) :4003 - 4011.
  • 9Press jz, De Luca A, Boyd N, et al. Ovarian carcinomas with genetic and epigenetic BRCAI loss have distinct molecular abnormalities[J]. BMC Cancer, 2008,8(1) : 17.
  • 10Milde-Langosch K, Ocon E, Becker G,et al. p16/MTSI inactivation in ovarian carcinomas: high frequency of reduced protein expression associated with hypermethylation or mutation in endometrioid and mucinous tumors [J]. Int 1 Cancer, 1998,79 ( 1 ) : 61 -65.

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部